ADIM
HIMS icon

Alpha DNA Investment Management’s Hims & Hers Health HIMS Stock Holding History

Alpha DNA Investment Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,986
Closed -$552K – 217
2024
Q3 		$552K Buy
+29,986
New +$537K 0.21% 100
2024
Q2 		– Sell
-31,744
Closed -$491K – 225
2024
Q1 		$491K Buy
+31,744
New +$358K 0.18% 157
2023
Q3 		– Sell
-86,031
Closed -$809K – 194
2023
Q2 		$809K Buy
+86,031
New +$853K 0.27% 92

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alpha DNA Investment Management's HIMS Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 29,986 shares — an estimated $552K sold.

Alpha DNA Investment Management first reported a position in HIMS in Q2 2023 and held it in 3 quarters. The position peaked at $809K in Q2 2023. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

  • Alpha DNA Investment Management reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 29,986 Hims & Hers Health shares in Q4 2024, an estimated $552K.
  • Alpha DNA Investment Management first reported a position in Hims & Hers Health in Q2 2023 and held it in 3 quarters.
  • Alpha DNA Investment Management's Hims & Hers Health position peaked at $809K in Q2 2023.
  • 394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.